Clinical trial Recruiting at 12 sites Observational Ages 18 and up

Registry for chronic rhinosinusitis outcomes

Official title: Real-Life Chronic Rhinosinusitis Outcome Registry

Run by Change Accelerator in Respiratory Care · NCT04670172 · Data updated 2026-11-12

This study is collecting information from people with chronic rhinosinusitis to see how the condition affects their lives and to learn more about the best treatments available.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment4550 (estimated)
SponsorChange Accelerator in Respiratory Care
Industry-sponsored
Locations13 sites (Graz and 12 other locations)
StatusRecruiting
StartedJanuary 1, 2021
Main results expectedJune 30, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 13, 2025
Trial IDNCT04670172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients diagnosed with chronic rhinosinusitis who can use a mobile application.

Probably not a fit

Patients with malignancies of the sinonasal cavity, inverted papilloma, or unilateral disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects real-life data from patients with chronic rhinosinusitis attending specialist care centers across Europe. It aims to understand the burden of the disease, its impact on quality of life, and productivity loss, while also evaluating treatment effectiveness and identifying patients eligible for targeted biologic therapy. The data will be centralized in a pseudonymized database, utilizing a mobile application for patients and an online dashboard for physicians to facilitate ongoing research and insights. The study will also assess the societal costs associated with chronic rhinosinusitis and its treatment.

Why it matters

Potential benefit: If successful, this registry could lead to improved management and treatment options for patients with chronic rhinosinusitis.

How similar studies have gone: Other studies have successfully utilized outcome registries to improve understanding and treatment of chronic respiratory diseases, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Physician diagnosis of Chronic RhinoSinusitis
* Capable of using a mobile application on a smartphone

Exclusion Criteria:

* Patients with malignancies of the sinonasal cavity
* Patients with inverted papilloma
* Patients with unilateral disease

Where it's running

  • Graz University Hospital
    Graz, Austria
    Recruiting
  • University Hospital Vienna
    Vienna, Austria
    Recruiting
  • UCL Saint-Luc
    Brussels, Belgium
    Recruiting
  • UZ Ghent
    Ghent, Belgium
    Recruiting
  • UZ Leuven
    Leuven, Belgium
    Recruiting
  • Odense University Hospital
    Odense, Denmark
    Recruiting
Show 7 more locations
  • CHU Lille
    Lille, France
    Recruiting
  • Dusseldorf University Clinic
    Düsseldorf, Germany
    Recruiting
  • Policlinico Umberto I
    Rome, Italy
    Recruiting
  • UMC Amsterdam
    Amsterdam, Netherlands
    Recruiting
  • Hospital Clinic de Barcelona
    Barcelona, Spain
    Recruiting
  • Prof Claire Hopkins private practice
    London, United Kingdom
    Recruiting
  • Helsinki University Hospital
    Helsinki, Finland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.